Journal of Ethnopharmacology 2014-10-28

Anti-diabetic and spasmolytic potential of Farsetia hamiltonii Royle from Cholistan desert.

Muhammad Munawar Hayat, Sadia Sarwar, Shazia Anjum, Muhammad Uzair, Hafiz Muhammad Farhan Rasheed, Qaiser Jabeen, Bashir Ahmad Choudhary, Muhammad Ashraf

Index: J. Ethnopharmacol. 156 , 347-52, (2014)

Full Text: HTML

Abstract

Folk herbal practitioners of the Cholistan desert claim Farsetia hamiltonii Royle (Brassicaceae) to treat diabetes, oxidative damages, diarrhea, fever, and abdominal cramps. The aim of this study was to scientifically find the potential of Farsetia hamiltonii in treating diabetes and gastrointestinal diseases.In vivo anti-diabetic activity of Farsetia hamiltonii was studied on alloxan induced diabetic rats to justify its traditional use. The in vitro antispasmodic activity on isolated tissues of rabbit jejunum was also evaluated. In addition, several enzyme inhibition studies (lipoxygenase, tyrosinase, acetylcholinesterase (AchE), carbonic II anhydrase and phosphodiesterase I) and antioxidant activity of plant extracts were also conducted.In vivo experiments, Farsetia hamiltonii methanol extract (300 mg/kg) significantly lowered the fasting blood glucose (107.6 ± 1.249 mg/dL up to 4th day) comparable to positive control (Glibenclamide) throughout the study period. The in vitro antispasmodic activity on isolated tissues of rabbit jejunum on methanol extract showed concentration dependent (0.01-0.3 mg/ml) relaxation of spontaneous contractions with EC₅₀ value 0.011 µM and high K(+) (80 mM) induced contraction (0.01-0.1 mg/ml) with EC₅₀ value 0.066 mg/ml. Farsetia hamiltonii DCM and methanol extracts exhibited some antilipoxygenase activities while tyrosinase, acetylcholinesterase (AchE), carbonic II anhydrase, phosphodiesterase I, and antioxidant activity of plant extracts were not significant.Our results validate the traditional use of Farsetia hamiltonii for the traditional therapeutic potential in treating diabetes and gastrointestinal diseases.Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Related Compounds

Structure Name/CAS No. Articles
Methanol Structure Methanol
CAS:67-56-1
Dichloromethane Structure Dichloromethane
CAS:75-09-2
DPPH Structure DPPH
CAS:1898-66-4
Gallic acid Structure Gallic acid
CAS:149-91-7
1,1-DIPHENYL-2-PICRYLHYDRAZINE Structure 1,1-DIPHENYL-2-PICRYLHYDRAZINE
CAS:1707-75-1
HEPES Structure HEPES
CAS:7365-45-9
Baicalein Structure Baicalein
CAS:491-67-8
P-NITROPHENYLACETATE Structure P-NITROPHENYLACETATE
CAS:830-03-5
Quercetin dihydrate Structure Quercetin dihydrate
CAS:6151-25-3
Physostigmine Structure Physostigmine
CAS:57-47-6